Literature DB >> 11162395

Bacterial expression of an immunologically reactive PCV2 ORF2 fusion protein.

Q Liu1, P Willson, S Attoh-Poku, L A Babiuk.   

Abstract

The entire coding region of open reading frame 2 (ORF2) of porcine circovirus 2 (PCV2) was linked to the 3'-end of the maltose-binding protein (MBP)-His(8)-tag gene. The fusion protein was expressed as soluble form after induction by isopropylthio-beta-d-galactoside. MBP-His(8)-ORF2 was purified to homogeneity by immobilized metal affinity chromatography based on the interaction of the polyhistidine-tag with metal ions. Expression could represent 1% of the total protein in Escherichia coli, allowing approximately 1 mg of highly purified protein to be obtained per liter of bacterial culture. The fusion protein was recognized in Western blot by anti-PCV2 polyclonal antibody and swine sera with PCV2 infection. In addition, rabbit polyclonal antibody raised against purified MBP-His(8)-ORF2 fusion protein reacted with the ORF2 protein in immunoprecipitation. The availability of this fusion protein should permit a thorough study of prevalence of PCV2 infection in large-scale serological studies of field samples. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162395     DOI: 10.1006/prep.2000.1356

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  16 in total

1.  Development and application of a double-antigen sandwich enzyme-linked immunosorbent assay for detection of antibodies to porcine circovirus 2.

Authors:  Meng Ge; Wei Luo; Daliang Jiang; Runcheng Li; Wenwei Zhao; Guoliang Chen; Xingdong Yang; Xinglong Yu
Journal:  Clin Vaccine Immunol       Date:  2012-07-18

2.  The capsid protein of beak and feather disease virus binds to the viral DNA and is responsible for transporting the replication-associated protein into the nucleus.

Authors:  Livio Heath; Anna-Lise Williamson; Edward P Rybicki
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  Analysis of putative ORF3 gene within porcine circovirus type 2.

Authors:  Jia-Ling He; Dan Dai; Niu Zhou; Ji-Yong Zhou
Journal:  Hybridoma (Larchmt)       Date:  2012-06

4.  Prokaryotic expression and potential application of the truncated PCV-2 capsid protein.

Authors:  Zhong-zi Lou; Zhi-yong Li; Gang Wang; Jian-qiang Li; Xi Lan; Xue-rui Li; Xiang-ping Yin; Ji-xing Liu; Si-dang Liu
Journal:  Virol Sin       Date:  2010-04-09       Impact factor: 4.327

5.  Expression and antigenicity characterization for truncated capsid protein of porcine circovirus type 2.

Authors:  Zhongzi Lou; Xuerui Li; Zhiyong Li; Xiangping Yin; Baoyu Li; Xi Lan; Bin Yang; Yun Zhang; Jixing Liu
Journal:  Can J Vet Res       Date:  2011-01       Impact factor: 1.310

6.  Expression of porcine circovirus 2 ORF2 gene requires codon optimized E. coli cells.

Authors:  Maria Trundova; Vladimir Celer
Journal:  Virus Genes       Date:  2006-12-01       Impact factor: 2.332

7.  Evaluation of the efficacy of a novel porcine circovirus type 2 synthetic peptide vaccine.

Authors:  Jiwoon Jeong; Changhoon Park; Seeun Kim; Su-Jin Park; Ikjae Kang; Kee Hwan Park; Chanhee Chae
Journal:  Can J Vet Res       Date:  2018-04       Impact factor: 1.310

8.  Development and validation of an ELISA using a protein encoded by ORF2 antigenic domain of porcine circovirus type 2.

Authors:  Shi-Qi Sun; Hui-Chen Guo; De-Hui Sun; Shuang-Hui Yin; You-Jun Shang; Xue-Peng Cai; Xiang-Tao Liu
Journal:  Virol J       Date:  2010-10-19       Impact factor: 4.099

9.  Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli.

Authors:  Shuanghui Yin; Shiqi Sun; Shunli Yang; Youjun Shang; Xuepeng Cai; Xiangtao Liu
Journal:  Virol J       Date:  2010-07-21       Impact factor: 4.099

Review 10.  Current understanding of genomic DNA of porcine circovirus type 2.

Authors:  Qi-Zhuang Lv; Kang-Kang Guo; Yan-Ming Zhang
Journal:  Virus Genes       Date:  2014-07-11       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.